Geoffrey Rotstein - Equillium President CEO, Director

EQ -- USA Stock  

Quarterly Earning Report: November 21, 2019  

  CEO
Mr. Geoffrey Rotstein is President, Chief Executive Officer, Director of EQ Inc. Mr. Rotstein was reappointed as President in August 2012. Mr. Rotstein is currently the Chief Executive Officer of the Corporationrationration, a position he has held since January 2006, prior to that, he was the Chief Financial Officer of the Corporationrationration from March 1997 to December 2005. Mr. Rotstein is a member of the Young Presidents Organization and sits on the Board of Directors and advisory committees for various private and not for profit organizations
  CEO Since 2006  MBA    
858-412-5302  http://www.equilliumbio.com
Rotstein worked as a Chartered Accountant at Coopers & Lybrand in Toronto, a major global accounting firm, from September 1992 to February 1997 and received his C.A. designation in 1996 and his M.B.A. degree from York University in Toronto in 1992.

Management Efficiency

Similar Executives

Found 11 records

CEO Since

David ZaccardelliDova Pharmaceuticals
2018
Douglas FambroughDicerna Pharmaceuticals
2010
Ting ZhengGlobal Cord Blood Corporation
2017
Ryan WattsDenali Therapeutics
2016
Yue DengGlobal Cord Blood Corporation
N/A
Jeffrey BachaDelMar Pharmaceuticals
2018
Barry SimonNantKwest
2017
Rui ArashiyamaGlobal Cord Blood Corporation
N/A
Rick PaulsDiaMedica Therapeutics
2014
Alex SapirDova Pharmaceuticals
2017
Eddie GrayDynavax Technologies Corporatio
2013

Entity Summary

Equillium, Inc., a biotechnology company, develops products for autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Equillium, Inc. was founded in 2017 and is headquartered in San Diego, California. Equillium operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 16 people.Equillium (EQ) is traded on BATS Exchange in USA. It is located in 2223 Avenida De La Playa and employs 16 people. Equillium is listed under Pharmaceutical Products category by Fama And French industry classification.

Equillium Leadership Team

John Fisher, Independent Director
Jason Keyes, CFO
Anthony Tjan, Independent Director
Daniel Bradbury, Chairman of the Board, CEO
Krishna Polu, Chief Medical Officer
Marc Lavine, Independent Director
Charles McDermott, Independent Director
Bruce Steel, President Chief Business Officer and Director
Geoffrey Rotstein, President CEO, Director
Bala Manian, Independent Director
Dilshan Kathriarachchi, CTO
Stephen Connelly, Chief Scientific Officer, Director
Peter Kanniah, CFO, Secretary
Martha Demski, Independent Director
Mark Pruzanski, Independent Director
Vernon Lobo, Independent Chairman of the Board

Stock Performance Indicators

Current Sentiment - EQ

Equillium Investor Sentiment

Larger part of Macroaxis users are currently bullish on Equillium. What is your opinion about investing in Equillium? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Equillium Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Equillium and Global Cord Blood. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see Investing Opportunities. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.
Search macroaxis.com